Integrative Analysis of Incongruous Cancer Genomics and Proteomics Datasets

Area of Science:

• Oncology
• Systems Biology
• Bioinformatics

Background:

• Cancer is a complex disease with poorly understood pathophysiology, marked by molecular heterogeneity.
• Current biomarker discovery often focuses on single molecule types (e.g., transcripts, proteins) due to data heterogeneity.
• There is a need to understand molecular interactions for a comprehensive view of cancer mechanisms.

Purpose of the Study:

• To describe a novel protocol for integrative analysis of multi-platform cancer datasets.
• To enable cross-comparison of different studies and data types using a systems biology approach.
• To identify commonalities and map deregulated molecular pathways in cancer.

Main Methods:

• Developed a systems biology protocol for integrative analysis of publicly available cancer datasets.
• Organized diverse datasets into a standardized format for integration and cross-comparison.
• Employed an unbiased, hypothesis-free methodology for data analysis.

Main Results:

• The protocol facilitates the integration and comparison of heterogeneous, large-scale datasets.
• Identified commonalities across different data sources and experimental platforms.
• Enabled mapping and characterization of specific molecular pathways involved in cancer.

Conclusions:

• The integrative systems biology approach provides a comprehensive strategy for analyzing cancer "big data".
• This methodology generates novel insights into the mechanisms underlying complex diseases like cancer.
• Facilitates a deeper understanding of molecular interactions driving cancer pathogenesis.